Dr Simon G Danby

All publications

Journal articles

• Cork MJ, Ong P, Danby SG, Ramirez-Gama M, Garcia S, Taylor P, Zahn J, Bologna G, Zhang A & Leung DYM (2024) 53081 Dupilumab Treatment Provides Sustained Improvement in Skin Barrier Function, Clinical Outcomes, and Patient-Reported Outcomes in Patients Aged 6 to 11 Years With Moderate-to-Severe Atopic Dermatitis. Journal of the American Academy of Dermatology, 91(3), AB34-AB34.
• Cork MJ, Berdyshev E, Goleva E, Danby SG, Bronova I, Zahn J, Agueusop I, Bafna S, Ong P, Zhang A & Leung DYM (2024) 52273 Dupilumab Provides Sustained Normalization of Skin Barrier Function in Children With Moderate-to-Severe Atopic Dermatitis. Journal of the American Academy of Dermatology, 91(3), AB34-AB34.
• Danby S, Andrew P, Brown K, Chittock J, Pinnock A, Williams S & Cork M (2024) 52909 MOISTURIZER WITH SKIN IDENTICAL LIPIDS RESTORES BARRIER FUNCTION IN ECZMEA-PRONE SKIN AND REDUCES SKIN SUSCEPTIBILITY TO IRRITANTS. Journal of the American Academy of Dermatology, 91(3), AB259-AB259.
• Ng SP, Bielfeldt S, Laing S, Danby S & Cork MJJ (2024) Effects of a pH-regulating emollient cream in mild atopic dermatitis patients with moderate localized lesions. Skin Pharmacology and Physiology, 37, 49-58. View this article in WRRO
• Berdyshev E, Goleva E, Danby S, Bronoff A, Agueusop I, Zahn J, Gloaguen E, Bissonnette R, Boguniewicz M, Ong P , Zhang A et al (2024) 280 Children with atopic dermatitis respond more rapidly to dupilumab treatment in comparison to adolescents and adults. Journal of Investigative Dermatology, 144(8), S48-S48.
• Cork MJ, Leung D, Ong P, Danby S, Ramirez-Gama M, Garcia S, Patricia T, Byers R, Matcher S, Zahn J , Bologna G et al (2024) P036 Dupilumab treatment normalizes skin barrier function in children aged 6–11 years with moderate-to-severe atopic dermatitis. British Journal of Dermatology, 191(Supplement_1), i30-i30.
• Cork M, Danby S, Rossi AB & Bansal A (2024) Dupilumab treatment in pediatric patients aged 6–11 years with severe atopic dermatitis whose disease Is not adequately controlled: a review. Drug Design, Development and Therapy, 18, 277-289. View this article in WRRO
• Bronova I, Berdyshev E, Goleva E, Danby S, Bronoff AS, Richers B, Garcia S, Gama MR, Taylor P, Zahn J , Agueusop I et al (2024) Dupilumab Improves Skin Lipid Barrier in Pediatric Patients With Moderate-to-Severe Atopic Dermatitis. Journal of Allergy and Clinical Immunology, 153(2), AB5-AB5.
• Chittock J, Kay L, Brown K, Cooke A, Lavender T, Cork MJ & Danby SG (2023) Association between skin barrier development and early-onset atopic dermatitis: a longitudinal birth cohort study. Journal of Allergy and Clinical Immunology. View this article in WRRO
• Williams S & Danby S (2023) P26 Characterization of skin barrier defects in atopic dermatitis patients using attenuated total reflection Fourier transform infrared spectroscopy. British Journal of Dermatology, 189(1), e24-e24.
• Winder N, Ashraf Z, Gohar S, Baalbaki N, Cork M, Danby S & Muthana M (2023) Are mild cleansers appropriate for hand hygiene in the COVID era? An in vitro investigation of the antiviral efficacy of different hand hygiene products. Frontiers in Virology, 3.
• van den Bogaard EH, Elias PM, Goleva E, Berdyshev E, Smits JPH, Danby SG, Cork M & Leung DYM (2023) Targeting skin barrier function in atopic dermatitis. The Journal of Allergy and Clinical Immunology: In Practice.
• Harding AL, Colley HE, Barragan Vazquez I, Danby S, Hasan MZ, Nakanishi H, Furuno T & Murdoch C (2022) c‐Src activation as a potential marker of chemical‐induced skin irritation using tissue‐engineered skin equivalents. Experimental Dermatology. View this article in WRRO
• Chittock J, Cork MJ & Danby SG (2022) REAL-TIME INFRARED Spectroscopic measurement of Natural Moisturising Factor. Journal of Investigative Dermatology.
• Uchegbulam I, Danby SG, Lewis R, Carré MJ & Maiti R (2022) Effect of seasonal change on the biomechanical and physical properties of the human skin. Journal of the Mechanical Behavior of Biomedical Materials, 127. View this article in WRRO
• Katibi OS, Cork MJ, Flohr C & Danby SG (2022) Moisturizer therapy in prevention of atopic dermatitis and food allergy: to use or disuse?. Annals of Allergy, Asthma & Immunology.
• Danby SG, Andrew PV, Taylor RN, Kay LJ, Chittock J, Pinnock A, Ulhaq I, Fasth A, Carlander K, Holm T & Cork MJ (2022) Different types of emollient cream exhibit diverse physiological effects on the skin barrier in adults with atopic dermatitis. Clinical and Experimental Dermatology.
• Danby SG, Andrew PV, Kay LJ, Pinnock A, Chittock J, Brown K, Williams SF & Cork MJ (2021) Enhancement of stratum corneum lipid structure improves skin barrier function and protects against irritation in adults with dry, eczema‐prone, skin. British Journal of Dermatology.
• Harding AL, Murdoch C, Danby S, Hasan MZ, Nakanishi H, Furuno T, Hadad S, Turner R & Colley HE (2021) Determination of chemical irritation potential using a defined gene signature set on tissue-engineered human skin equivalents. JID Innovations, 100011-100011. View this article in WRRO
• Lin WC, Byers R, Li W, Danby S, Cork M & Matcher S (2021) Imaging striae distensae: a comparisonbetween PS-OCT and digital dermoscopy. Biomedical Optics Express.
• Danby SG, Andrew P, Kay L, Pinnock A, Brown K & Cork MJ (2020) 16818 An investigation of the skin barrier restoring effects of a cream containing ceramides in a multivesicular emulsion in people with dry, eczema-prone, skin: The RESTORE study phase 2. Journal of the American Academy of Dermatology, 83(6), AB71-AB71.
• Danby SG, Draelos ZD, Gold LFS, Cha A, Vlahos B, Aikman L, Sanders P, Wu-Linhares D & Cork MJ (2020) Vehicles for atopic dermatitis therapies: more than just a placebo. Journal of Dermatological Treatment. View this article in WRRO
• Danby SG, Andrew PV, Brown K, Chittock J, Kay LJ & Cork MJ (2020) An investigation of the skin barrier restoring effects of a cream and lotion containing ceramides in a multi-vesicular emulsion in people with dry, eczema-prone, skin: The RESTORE study phase 1. Dermatology and Therapy. View this article in WRRO
• Maiti R, Duan MQ, Danby S, Lewis R, Matcher SJ & Carré MJ (2019) Morphological parametric mapping of 21 skin sites throughout the body using optical coherence tomography. Journal of the Mechanical Behavior of Biomedical Materials. View this article in WRRO
• Jabbar-Lopez ZK, Gurung N, Greenblatt D, Briley A, Chalmers JR, Thomas KS, Frost T, Kezic S, Common JEA, Kong HH , Segre JA et al (2019) Protocol for an outcome assessor-blinded pilot randomised controlled trial of an ion-exchange water softener for the prevention of atopic eczema in neonates, with an embedded mechanistic study : the softened water for eczema prevention (SOFTER) trial. BMJ Open, 9(8). View this article in WRRO
• Alexander H, Brown S, Danby S & Flohr C (2018) Research Techniques Made Simple: Transepidermal Water Loss Measurement as a Research Tool. Journal of Investigative Dermatology, 138(11), 2295-2300.e1.
• Chalmers JR & Danby S (2018) Towards a better understanding of outcome measurement instruments for atopic eczema.. Br J Dermatol, 179(2), 246-247.
• Liu Q, Zhang Y, Danby SG, Cork M & Stamatas G (2018) Infant Skin Barrier, Structure, and Enzymatic Activity Differ from Those of Adult in an East Asian Cohort. BioMed Research International, 2018. View this article in WRRO
• Byers RA, Maiti R, Danby SG, Pang EJ, Mitchell B, Carré MJ, Lewis R, Cork MJ & Matcher SJ (2018) Sub-clinical assessment of atopic dermatitis severity using angiographic optical coherence tomography. Biomedical Optics Express, 9(4), 2001-2001. View this article in WRRO
• Danby SG, Brown K, Wigley A, Chittock J, Pyae P, Flohr C & Cork M (2018) The Effect of Water Hardness on Surfactant Deposition after Washing and Subsequent Skin Irritation in Atopic Dermatitis Patients and Healthy Control Subjects. Journal of Investigative Dermatology, 138(1), 68-77. View this article in WRRO
• Danby SG (2017) Staphylococcus aureus in atopic dermatitis: a diverse problem?. British Journal of Dermatology, 177(5), 1164-1164.
• Cork MJ & Danby SG (2017) The British Skin Foundation: 20 years of supporting dermatology research. British Journal of Dermatology, 177(3), 608-609.
• Christodoulides P, Hirata Y, Dominguez-Huttinger E, Danby SG, Cork M, Williams HC, Aihara K & Tanaka R (2017) Computational design of treatment strategies for proactive therapy on atopic dermatitis using optimal control theory. Royal Society of London. Philosophical Transactions A. Mathematical, Physical and Engineering Sciences, 375(2096). View this article in WRRO
• Danby SG, Wigley A, Cork MJ & Cork MJ (2017) Biologic Treatments for Atopic Eczema: Anti IL-4 and IL-13 biologics. Exchange: National Eczema Society Members' Magazine(163), 11-18. View this article in WRRO
• Albenali LH, Danby S, Moustafa M, Brown K, Chittock J, Shackley F & Cork MJ (2016) Vitamin D and antimicrobial peptide levels in patients with atopic dermatitis and atopic dermatitis complicated by eczema herpeticum: A pilot study. Journal of Allergy and Clinical Immunology, 138(5), 1715-1719.e4. View this article in WRRO
• Danby SG, Chalmers J, Brown K, Williams HC & Cork MJ (2016) A functional mechanistic study of the effect of emollients on the structure and function of the skin barrier. British Journal of Dermatology, 175(5), 1011-1019. View this article in WRRO
• Chittock J, Cooke A, Lavender T, Brown K, Wigley A, Victor S, Cork MJ & Danby SG (2016) Development of stratum corneum chymotrypsin-like protease activity and natural moisturizing factors from birth to 4 weeks of age compared with adults. British Journal of Dermatology, 175(4), 713-720. View this article in WRRO
• Danby SG, Brown K, Higgs-Bayliss T, Chittock J, Albenali L & Cork M (2016) The Effect of an Emollient Containing Urea, Ceramide NP, and Lactate on Skin Barrier Structure and Function in Older People with Dry Skin. Skin Pharmacology and Physiology, 29(3), 135-147. View this article in WRRO
• Danby SG (2016) Biological Variation in Skin Barrier Function: From A (Atopic Dermatitis) to X (Xerosis). Current Problems in Dermatology (Switzerland), 49, 47-60.
• Cooke A, Cork M, Victor S, Campbell M, Danby S, Chittock J & Lavender T (2016) Olive Oil, Sunflower Oil or no Oil for Baby Dry Skin or Massage: A Pilot, Assessor-blinded, Randomized Controlled Trial (the Oil in Baby SkincaRE [OBSeRvE] Study). Acta Dermato Venereologica, 96(3), 323-330.
• Chittock J, Brown K, Cork M & Danby S (2015) Comparing the Effect of a Twice-weekly Tacrolimus and Betamethasone Valerate Dose on the Subclinical Epidermal Barrier Defect in Atopic Dermatitis. Acta Dermato Venereologica, 95(6), 653-658.
• Cowdell F, Jadotte JT, Ersser SJ, Danby SG, Walton S, Lawton S, Roberts A, Gardiner E, Ware F & Cork MJ (2014) Hygiene and emollient interventions for maintaining skin integrity in older people in hospital and residential care settings. Cochrane Database of Systematic Reviews, 2014(12), 1-16.
• Danby SG (2014) A new perspective on histamine in atopic dermatitis. British Journal of Dermatology, 171(4), 688-688.
• Danby SG, Chittock J, Brown K, Albenali LH & Cork MJ (2014) The effect of tacrolimus compared with betamethasone valerate on the skin barrier in volunteers with quiescent atopic dermatitis.. Br J Dermatol, 170(4), 914-921.
• Danby SG & Cork MJ (2013) The effects of pimecrolimus on the innate immune response in atopic dermatitis.. Br J Dermatol, 168(2), 235-236.
• Lu Z, Boadi J, Danby S, Cork M & Matcher SJ (2013) Optical coherence tomography demonstrates differential epidermal thinning of human forearm volar skin after 2 weeks application of a topical corticosteroid vs a non-steroidal anti-inflammatory alternative. Photonic Therapeutics and Diagnostics IX.
• Danby SG, AlEnezi T, Sultan A, Lavender T, Chittock J, Brown K & Cork MJ (2013) Effect of olive and sunflower seed oil on the adult skin barrier: implications for neonatal skin care.. Pediatr Dermatol, 30(1), 42-50.
• Cork MJ & Danby S (2011) Aqueous cream damages the skin barrier. British Journal of Dermatology, 164(6), 1179-1180.
• Danby SG, Al-Enezi T, Sultan A, Chittock J, Kennedy K & Cork MJ (2011) The effect of aqueous cream BP on the skin barrier in volunteers with a previous history of atopic dermatitis.. Br J Dermatol, 165(2), 329-334.
• Cooke A, Cork MJ, Danby SG & Lavender T (2011) Use of oil for baby skincare: A survey of UK maternity and neonatal units. British Journal of Midwifery, 19(6), 354-362.
• Cooke A, Cork MJ, Danby S & Lavender T (2011) Use of oil for baby skincare: A survey of UK maternity and neonatal units. British Journal of Midwifery, 19(6), 354-362.
• Danby SG & Cork MJ (2010) A New Understanding Of Atopic Dermatitis: The Role Of Epidermal Barrier Dysfunction And Subclinical Inflammation. Journal of Clinical Dermatology, 1, 33-46.
• Danby SG (2010) Expression of the multi-drug efflux genes acrAB of 'Escherichia coli'..
• Cork MJ, Danby SG, Vasilopoulos Y, Hadgraft J, Lane ME, Moustafa M, Guy RH, Macgowan AL, Tazi-Ahnini R & Ward SJ (2009) Epidermal barrier dysfunction in atopic dermatitis.. J Invest Dermatol, 129(8), 1892-1908.
• Cork MJ & Danby S (2009) Skin barrier breakdown: a renaissance in emollient therapy. British Journal of Nursing, 18(14), 872-877.
• Cork MJ, Danby SG, Vasilopoulos Y, Moustafa M, MacGowan A, Vargese J, Duff G, Tazi-Ahnini R & Ward SJ (2008) Gene-environment interactions in atopic dermatitis. Drug Discovery Today: Disease Mechanisms, 5, e11-e31.
• Cork MJ, Danby S, Vasilopoulos Y, Moustafa M, MacGowan A, Varghese J, Duff GW, Tazi-Ahnini R & Ward SJ (2008) Gene–environment interactions in atopic dermatitis. Drug Discovery Today: Disease Mechanisms, 5(1), e11-e31.
• Rand JD, Danby SG, Greenway DLA & England RR (2002) Increased expression of the multidrug efflux genes acrAB occurs during slow growth of Escherichia coli.. FEMS Microbiol Lett, 207(1), 91-95.
• Rand JD, Danby SG, Greenway DLA & England RR (2002) Increased expression of the multidrug efflux genesacrABoccurs during slow growth ofEscherichia coli. FEMS Microbiology Letters, 207(1), 91-95.
• Haag C, Alexis A, Aoki V, Bissonnette R, Blauvelt A, Chovatiya R, Cork MJ, Danby SG, Eichenfield L, Eyerich K , Gooderham M et al () A Practical Guide to Using Oral JAK Inhibitors for Atopic Dermatitis from the International Eczema Council. British Journal of Dermatology.
• Danby SG, Matcher S, Byers R, Taylor R, Sahib S, Andrew P, Brown K, Kay L, Wright C, Pinnock A , Chittock J et al () Novel biophysical skin biomarkers discriminate topical anti‐inflammatory treatments based on their potential for local adverse effects. JEADV Clinical Practice.
• Danby SG () Debunking the myth that all emollients are equal opens the door for future AD prevention studies. British Journal of Dermatology.
• Andrew PV, Pinnock A, Poyner A, Brown K, Chittock J, Kay LJ, Cork MJ & Danby SG () Maintenance of an Acidic Skin Surface with a Novel Zinc Lactobionate Emollient Preparation Improves Skin Barrier Function in Patients with Atopic Dermatitis. Dermatology and Therapy.
• Williams SF, Wan H, Chittock J, Brown K, Wigley A, Cork MJ & Danby SG () Characterisation of skin barrier defects in atopic dermatitis patients using Infrared Spectroscopy. Clinical and Experimental Dermatology.
• Duan M, Byers R, Danby S, sahib S, cha A, zang C, werth J, adiri R, Taylor RN, Cork M & Matcher S () The potential application of PS-OCT in the safety assessment of non-steroidal topical creams for Atopic Dermatitis treatment. Biomedical Optics Express.
• Jabbar‐Lopez ZK, Ezzamouri B, Briley A, Greenblatt D, Gurung N, Chalmers JR, Thomas KS, Frost T, Kezic S, Common JEA , Danby S et al () Randomized controlled pilot trial with ion‐exchange water softeners to prevent eczema (SOFTER trial). Clinical & Experimental Allergy.
• Jabbar‐Lopez ZK, Ung CY, Alexander H, Gurung N, Chalmers J, Danby S, Cork MJ, Peacock JL & Flohr C () The effect of water hardness on atopic eczema and skin barrier function: A systematic review and meta‐analysis. Clinical & Experimental Allergy.
• Cowdell F, Jadotte YT, Ersser SJ, Danby S, Lawton S, Roberts A & Dyson J () Hygiene and emollient interventions for maintaining skin integrity in older people in hospital and residential care settings. Cochrane Database of Systematic Reviews.
• Oakley R, Arents BWM, Lawton S, Danby S & Surber C () Topical corticosteroid vehicle composition and implications for clinical practice. Clinical and Experimental Dermatology.
• Cork MJ, Danby SG & Ogg GS () Atopic dermatitis epidemiology and unmet need in the United Kingdom. Journal of Dermatological Treatment. View this article in WRRO
• Danby SG, Andrew PV, Brown K, Chittock J, Kay LJ & Cork MJ () Response to: Letter to the Editor Regarding “An Investigation of the Skin Barrier Restoring Effects of a Cream and Lotion Containing Ceramides in a Multi-Vesicular Emulsion in People with Dry, Eczema-Prone, Skin: The RESTORE Study Phase 1”. Dermatology and Therapy.

Chapters

• Danby SG & Cork MJ (2018) pH in Atopic Dermatitis, pH of the Skin: Issues and Challenges (pp. 95-107). S. Karger AG
• Danby S, Bedwell C & Cork MJ (2014) Neonatal Skin Care and Toxicology In Eichenfield LF, Frieden IJ, Zaenglein A & Mathes E (Ed.), Neonatal and Infant Dermatology (pp. 46-56). Saunders
• Cork MJ & Danby SG (2012) Current and Future Trends: Skin Diseases and Treatment In Benson HAE & Watkinson AC (Ed.), Topical and Transdermal Drug Delivery Wiley
• Cork MJ & Danby S (2011) The Skin Barrier in Atopic Dermatitis. In Irvine A, Hoeger P & Yan A (Ed.), Textbook of Pediatric Dermatology, UK: Blackwell Publishing Ltd..
• Cork MJ, Moustafa M, Danby S, Vasilopoulos Y, Tazi-Ahnini R, Ward SJ, Hadgraft J, Lane ME, Guy R & MacGowan A (2009) Skin Barrier Dysfunction in Atopic Dermatitis, Basic and Clinical Dermatology (pp. 211-240). Informa Healthcare
• Cork MJ, Danby SG, Vasilopoulos Y, Hadgraft J, Lane M, Moustafa M, Guy R, MacGowan A, Tazi-Ahnini R & Ward SJ (2009) Epidermal Barrier Dysfunction in Atopic Dermatitis In Rawlings L (Ed.), Skin Moisturization USA: Informa Healthcare USA Inc..

Conference proceedings papers

• Cork MJ, Leung DYM, Ong P, Danby SG, Ramirez-Gama M, Garcia S, Taylor P, Zahn J, Praestgaard A, Bologna G & Zhang A (2023) 55 Dupilumab treatment normalizes skin barrier function and improves patient-reported outcomes in patients aged 6 to 11 years with moderate-to-severe atopic dermatitis. Journal of Investigative Dermatology, Vol. 143(11) (pp S342-S342)
• Cork MJ, Leung DYM, Ong P, Danby SG, Ramirez-Gama M, Garcia S, Taylor P, Zahn J, Praestgaard A, Bologna G & Zhang A (2023) Dupilumab treatment normalizes skin barrier function and improves patient-reported outcomes in patients aged 6 to 11 years with moderate-to-severe atopic dermatitis. JOURNAL OF INVESTIGATIVE DERMATOLOGY, Vol. 143(11) (pp S342-S342)
• Vazquez IB, Danby S, Garcia Gonzalez VM, Lopez Almagro R, Crespo Crespo MI, Colley H & Murdoch C (2023) AN IN VITRO IMMUNOCOMPETENT HUMAN TISSUE-ENGINEERED MODEL OF ATOPIC DERMATITIS FOR DRUG TESTING. TISSUE ENGINEERING PART A, Vol. 29(11-12) (pp 492-492)
• Barragan Vazquez I, Danby S, Garcia Gonzalez VM, Lopez Almagro R, Colley HE & Murdoch C (2022) P39: Development of an in vitro immunocompetent human skin-equivalent model. British Journal of Dermatology, Vol. 187(1) (pp E29-E29). Virtual, 29 March 2021 - 29 March 2021. View this article in WRRO
• Harding A, Danby S, Murdoch C, Hasan MZ & Colley H (2022) P42: Development and validation of tissue-engineered human skin equivalents to detect stinging potential. British Journal of Dermatology, Vol. 187(1) (pp E31-E31). Virtual, 29 March 2021 - 29 March 2021. View this article in WRRO
• Danby SG, Andrew PV, Taylor RN, Kay LJ, Chittock J, Pinnock A, Ulhaq I, Fasth A, Carlander K, Holm T , Cork MJ et al (2022) EFFECTS OF EMOLLIENT CREAMS ON THE SKIN BARRIER OF PATIENTS WITH ATOPIC DERMATITIS. ACTA DERMATO-VENEREOLOGICA, Vol. 102 (pp 35-36)
• Chittock J, Kay L, Brown K, Cooke A, Lavender T, Cork MJ & Danby SG (2022) SKIN TESTING TO DETERMINE ATOPIC DERMATITIS RISK: AN OBSERVATIONAL BIRTH COHORT STUDY. ACTA DERMATO-VENEREOLOGICA, Vol. 102 (pp 15-15)
• Danby SG, Matcher S, Byers R, Taylor R, Sahib S, Andrew P, Brown K, Kay L, Wright C, Pinnock A , Chittock J et al (2022) A RANDOMIZED CONTROLLED PHASE 2 TRIAL COMPARING THE EFFECTS OF CRISABOROLE 2% OINTMENT TO BETAMETHASONE VALERATE 0.1% CREAM ON SKIN STRUCTURE IN PARTICIPANTS WITH ATOPIC DERMATITIS. ACTA DERMATO-VENEREOLOGICA, Vol. 102 (pp 56-57)
• Lin WC, Byers R, Danby S & Matcher S (2022) Assessing the severity of striae distensae using polarization-sensitive optical coherence tomography. BRITISH JOURNAL OF DERMATOLOGY, Vol. 187(1) (pp E22-E23)
• Danby SG, Andrew PV, Pinnock A, Kay L, Chittock J & Cork MJ (2021) LOWERING SKIN SURFACE PH WITH A TOPICAL ZINC LACTOBIONATE PREPARATION CONTAINING PHYSIOLOGIC LIPIDS IMPROVES SKIN BARRIER STRUCTURE AND FUNCTION IN ADULTS WITH ATOPIC DERMATITIS. ACTA DERMATO-VENEREOLOGICA, Vol. 101 (pp 51-51)
• Danby SG, Andrew P, Kay L, Pinnock A, Chittock J, Brown K & Cork MJ (2020) An investigation of the skin barrier restoring effects of a cream containing ceramides in a multivesicular emulsion in people with dry, eczema-prone, skin: The RESTORE study phase 2. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, Vol. 83(6) (pp AB71-AB71)
• Chittock J, Brown K, Cork MJ & Danby SG (2018) Quantification of natural moisturizing factors at the skin surface using a portable infrared spectrometer device: a pilot, calibration model. BRITISH JOURNAL OF DERMATOLOGY, Vol. 179(1) (pp E35-E36) View this article in WRRO
• Byers RA, Maiti R, Danby SG, Pang EJ, Mitchell B, Carré MJ, Lewis R, Cork MJ & Matcher SJ (2017) Characterizing the microcirculation of atopic dermatitis using angiographic optical coherence tomography. Proceedings of SPIE, Vol. 10037 View this article in WRRO
• Jabbar-Lopez Z, Phongphit V, Ung CY, Chalmers J, Danby S, Peacock J & Flohr C (2017) The role of domestic water hardness in the development of skin barrier dysfunction and atopic eczema: a systematic review of the literature. BRITISH JOURNAL OF DERMATOLOGY, Vol. 177 (pp 159-159)
• Danby S, Wan H, Chittock J, Brown K, Wigley A & Cork M (2016) 129 Characterisation of the skin barrier defect in atopic dermatitis using in vivo ATR-FTIR spectroscopy. Journal of Investigative Dermatology, Vol. 136(9) (pp S182-S182)
• Cooke A, Cork M, Victor S, Campbell M, Danby S, Chittock J & Lavender T (2015) A pilot, assessor-blinded, randomized controlled trial of topical oils for neonatal skin. BRITISH JOURNAL OF DERMATOLOGY, Vol. 173 (pp 153-153)
• Higgs-Bayliss T, Brown K, Chittock J, Cork MJ & Danby SG (2014) Noninvasive assessment of the lipid structure and water holding properties of the stratum corneum in vivo by ATR-FTIR using a fibre optic probe in patients with atopic dermatitis and healthy controls. BRITISH JOURNAL OF DERMATOLOGY, Vol. 170(6) (pp E29-E29)
• Danby S, Brown K, Higgs-Bayliss T, Chittock J & Cork M (2014) The effect of a complex emollient cream containing 5% urea, ceramide 3 and lactic acid, compared with a simple emollient, on the skin barrier in older people with dry skin. BRITISH JOURNAL OF DERMATOLOGY, Vol. 171 (pp 57-58)
• Danby S, Chittock J, Martin KM, Cork MJ & Tierney NK (2013) Chymotrypsin-like protease activity in the stratum corneum is increased in atopic dermatitis and upon washing with soap. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, Vol. 68(4) (pp AB172-AB172)
• Albenali L, Danby S, Moustafa M, Chittock J, Kennedy K, Shackley F & Cork MJ (2012) Vitamin D supplementation improves atopic dermatitis and atopic dermatitis complicated by eczema herpeticum. BRITISH JOURNAL OF DERMATOLOGY, Vol. 167 (pp 127-127)
• Danby S, Al Enezi T, Chittock J, Kennedy K, Sultan A & Cork M (2011) A randomized comparison of aqueous cream and Oilatum® Junior bath additive on skin barrier function in atopic dermatitis. BRITISH JOURNAL OF DERMATOLOGY, Vol. 165 (pp 44-45)
• Danby S, Al Enezi T, Chittock J, Kennedy K, Sultan A & Cork M (2011) A randomized comparison of aqueous cream and Oilatum® Junior bath additive on skin barrier function in atopic dermatitis. BRITISH JOURNAL OF DERMATOLOGY, Vol. 165 (pp 115-115)
• Danby S, Moustafa M, MacGowan AL, Ward SJ & Cork MJ (2009) Skin protease inhibitors: a new treatment for atopic dermatitis. BRITISH JOURNAL OF DERMATOLOGY, Vol. 161 (pp 30-31)
• (2009) British Society for Paediatric Dermatology. British Journal of Dermatology, Vol. 161 (pp 115-127)
• Danby S, Moustafa M, MacGowan AL, Ward SJ & Cork MJ (2009) Skin protease inhibitors: A new treatment for atopic dermatitis. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, Vol. 60(3) (pp AB67-AB67)

Reports

• Danby SG, Ewence A, Rumsby P, Cork MJ, Williams HC, Rockett L & Davey HMSAUIII-PP (2011) A systematic review of skin irritation and tap water

Posters

• Katibi OS, Andrew P, Poyner A, Pinnock A, Brown K, Byers R, Cork M & Danby S (2023) P24 Emollient use and effects on cutaneous allergen reactions: a preliminary study.